Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05572502 · ClinicalTrials.gov registry record · NA

Diabetes Reversal Online Program and Study (DROP Study)

A NA study of Type 2 Diabetes, sponsored by Physicians Committee for Responsible Medicine.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT05572502 is a NA study of Type 2 Diabetes that is actively recruiting participants, run by Physicians Committee for Responsible Medicine. The registered enrollment target is 150 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05572502, a NA study of Type 2 Diabetes, is actively recruiting participants, sponsored by Physicians Committee for Responsible Medicine.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This is an interventional study that will evaluate the feasibility, implementation, and efficacy of an online, 12-week, plant-based, nutrition education program in a community setting. Data will also be analyzed to see if participation in the program results in reductions glycated hemoglobin levels, body weight, and cholesterol levels.

Conditions Studied

Interventions

  • BEHAVIORAL plant-based diet

Study Locations (1)

District of Columbia

  • Physician Committee for Responsible Medicine - Washington D.C.

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2023-09-21
Est. Completion 2027-12-31
Phase NA

What the Registry Record Tells You About NCT05572502

The ClinicalTrials.gov registry entry for NCT05572502 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (86% lower). The listed sponsor is Physicians Committee for Responsible Medicine, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which plant-based diet is the first listed.

NCT05572502 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT05572502 about?

NCT05572502 is a clinical study titled "Diabetes Reversal Online Program and Study (DROP Study)". This is an interventional study that will evaluate the feasibility, implementation, and efficacy of an online, 12-week, plant-based, nutrition education program in a community setting. Data will also be analyzed to see if participation in the program results in reductions glycated hemoglobin levels,...

What is the current status of trial NCT05572502?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-09-21. Estimated completion is 2027-12-31.

What conditions does trial NCT05572502 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT05572502?

The interventions under investigation include: plant-based diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT05572502?

This trial is sponsored by Physicians Committee for Responsible Medicine, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05572502 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.